Doctors Use Genetically Engineered Viruses to Fight Drug-Resistant Superbug

Doctors Use Genetically Engineered Viruses to Fight Drug-Resistant Superbug

Antibiotics were miracle drugs for most of the 20th century, but they’re no longer a silver bullet that can treat any infection. Overuse of antibiotics has fostered the proliferation of resistant organisms that can prove life-threatening, especially to those with already weakened immune systems. A teenager in the UK was at death’s door following complications from a lung transplant, but a last-ditch effort using genetically engineered viruses has saved her life. Doctors say this is a watershed moment for the use of so-called bacteriophages in medicine.

Problems for 17-year-old Isabelle Carnell-Holdaway started when she was a toddler. Doctors diagnosed her with cystic fibrosis, a genetic disorder that cuts life expectancy in half. The only long-term treatment for CF at this time is a lung transplant. Carnell-Holdaway was able to get a transplant at age 15, but a low-grade chronic infection flourished while she was recovering and on immunosuppressant medications. The organism, a strain of Mycobacterium abscessus, proved resistant to all antibiotic treatments.

After exhausting all conventional treatment options, doctors looked to bacteriophages as a solution. These microscopic viruses don’t infect human cells, but they’re potentially deadly to bacteria. Doctors have used bacteriophages to treat infections in the past, but it’s a difficult and time-consuming process to find strains of phage that can successfully beat back an infection. In this case, doctors had access to a library of 15,000 phages assembled for a research project.

The team identified a phage called “Muddy” as the best candidate (see above). It was discovered in 2010 preying on bacteria in a rotting eggplant. Doctors found two other phages that could help and made alterations to their tiny genomes that made them more like Muddy — virulent and deadly to Mycobacterium abscessus.

Doctors Use Genetically Engineered Viruses to Fight Drug-Resistant Superbug

Beginning in June 2018, doctors administered the mix of three bacteriophages to Carnell-Holdaway twice daily. Over the next few months, the infection shrank until it had all but vanished. Remarkably, there have been no adverse side effects from flooding Carnell-Holdaway’s body with billions of phage particles every day.

Doctors are careful to point out that their patient isn’t “cured.” She still harbors the dangerous bacteria, and it could stage a comeback if the treatment is ended too soon. For now, Carnell-Holdaway is still getting injections of the phage cocktail daily. However, she has been able to resume a normal daily routine without the disabling effects of cystic fibrosis. The results of her treatment have been published in the journal Nature.

Continue reading

Scientists Develop Nasal Spray That Can Disable Coronavirus
Scientists Develop Nasal Spray That Can Disable Coronavirus

In a newly released study, the concoction was effective at deactivating the novel coronavirus before it could infect cells.

Android Antivirus Apps Are Useless — Here’s What to Do Instead
Android Antivirus Apps Are Useless — Here’s What to Do Instead

It's still on you to be aware of threats to stay safe, but Android is by its very nature more secure than a desktop computer. Still, you've probably already got what you need.

The Epstein-Barr Virus May Cause Multiple Sclerosis
The Epstein-Barr Virus May Cause Multiple Sclerosis

A study of over 10 million young adults reveals that prior EBV infection increases one's liklihood of developing MS 32-fold.

First Human Trial of Experimental Cancer-Killing Virus Underway
First Human Trial of Experimental Cancer-Killing Virus Underway

The virus targets cancer cells while delivering engineered white blood cells to the tumor, giving the patient's immune system a boost.